NF1 and acute lymphoblastic leukemia: The child was treated with a modified treatment plan based on the high-risk arm of AIEOP-BFM ALL 2009 with cumulative anthracycline capped at 270 mg/m2 due to NF-1 related altered cardiac architecture.